F/m Emerald Life Sciences Innovation ETF LFSC

Full chart Compare
Set alert

Price alert · LFSC

All alert types
45.66 USD +1.58 (+3.57%)

At closeNov 4, 2026, 4:00 PM EST

45.66 0.00 0.00%

After hours · Nov 4, 4:00 PM ET

44.76 Day range 45.78
31.02 52-week range 48.78
YTD
+24.67%
1 year
+43.62%

F/M Emerald Life Sciences Innovation ETF

Issuer
Emerald
Asset class
Equity
Expense ratio
0.79%
Assets under management
$123.00M
NAV
44.20
Holdings
0
Inception
2024-10-30
Top 10 weight
55.58%

Top holdings

  1. REPL Replimune Group Inc 10.09%
  2. LIVN LivaNova PLC 7.93%
  3. COGT Cogent Biosciences Inc 5.81%
  4. TVTX Travere Therapeutics Inc 5.74%
  5. GH Guardant Health Inc 5.10%
  6. BLLN Billiontoone Inc 4.87%
  7. CORT Corcept Therapeutics Inc 4.22%
  8. MANE VeraDermics Inc 3.98%
  9. SYRE Spyre Therapeutics Inc 3.96%
  10. UTHR United Therapeutics Corp 3.89%
  11. MIRM Mirum Pharmaceuticals Inc 3.71%
  12. CYTK Cytokinetics Inc 3.16%
  13. TMDX TransMedics Group Inc 2.92%
  14. ICUI ICU Medical Inc 2.81%
  15. AXSM Axsome Therapeutics Inc 2.49%
  16. SVRA Savara Inc 2.47%
  17. PVLA Palvella Therapeutics Inc 2.31%
  18. TRVI Trevi Therapeutics Inc 2.19%
  19. TWST Twist Bioscience Corp 2.08%
  20. CBLL Ceribell Inc 2.02%
  21. PRAX Praxis Precision Medicines Inc 1.86%
  22. VRDN Viridian Therapeutics Inc 1.74%
  23. NKTR Nektar Therapeutics 1.60%
  24. DNTH Dianthus Therapeutics Inc 1.52%
  25. CRVS Corvus Pharmaceuticals Inc 1.42%

Sector weights

  • Healthcare 100.00%

Country weights

  • United States 100.00%

Updated 2026-11-05

Held by funds

1 US ETFs and mutual funds hold LFSC · largest positions

Funds holding LFSC, by value held
FundValue heldWeight in fund
NMBL $852.26K3.61%

Top institutional holders

Top institutional holders
Holder% heldSharesValueReported
Financial Investors Tr-Emerald Growth Fund92.29%2,000,00047.48MOct 30, 2024